Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10415 (
Bcl-2
)
33,771
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The BH3-only BID protein (BH3-interacting domain death agonist) has a critical function in the death-receptor pathway in the liver by triggering mitochondrial outer membrane permeabilization (MOMP). Here we show that MTCH2/
MIMP
(mitochondrial carrier homologue 2/
Met-induced mitochondrial protein
), a novel truncated BID (tBID)-interacting protein, is a surface-exposed outer mitochondrial membrane protein that facilitates the recruitment of tBID to mitochondria. Knockout of MTCH2/
MIMP
in embryonic stem cells and in mouse embryonic fibroblasts hinders the recruitment of tBID to mitochondria, the activation of Bax/Bak, MOMP, and apoptosis. Moreover, conditional knockout of MTCH2/
MIMP
in the liver decreases the sensitivity of mice to Fas-induced hepatocellular apoptosis and prevents the recruitment of tBID to liver mitochondria both in vivo and in vitro. In contrast, MTCH2/
MIMP
deletion had no effect on apoptosis induced by other pro-apoptotic
Bcl-2
family members and no detectable effect on the outer membrane lipid composition. These loss-of-function models indicate that MTCH2/
MIMP
has a critical function in liver apoptosis by regulating the recruitment of tBID to mitochondria.
...
PMID:MTCH2/MIMP is a major facilitator of tBID recruitment to mitochondria. 2043 77